{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:37:20Z","timestamp":1785472640075,"version":"3.56.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ijantimicag.2004.08.003","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T19:05:09Z","timestamp":1100631909000},"page":"529-535","source":"Crossref","is-referenced-by-count":37,"title":["Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"24","author":[{"given":"George G.","family":"Zhanel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Schurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.08.003_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200262010-00002","article-title":"A critical review of the fluoroquinolones: focus on respiratory infections","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/374052","article-title":"Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998\u20132002)","volume":"36","author":"Karlowsky","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0163-4453(03)00123-3","article-title":"Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000\u20132001","volume":"48","author":"Doern","year":"2004","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0732-8893(03)00140-8","article-title":"The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999\u20132002","volume":"47","author":"Jones","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib6","doi-asserted-by":"crossref","unstructured":"NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002. Issued August 2002. Am J Infect Control 2002;30:458\u201375.","DOI":"10.1067\/mic.2002.130032"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/45.suppl_3.95","article-title":"Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae","volume":"45","author":"Broskey","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The importance of efflux pumps in bacterial antibiotic resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib9","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.77.7.3974","article-title":"Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli","volume":"77","author":"McMurry","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0006-291X(80)80247-6","article-title":"Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic","volume":"93","author":"Ball","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.46.3.813-820.2002","article-title":"Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae","volume":"46","author":"Piddock","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib12","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1128\/AAC.43.12.2998","article-title":"Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms","volume":"43","author":"Heaton","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/dkf095","article-title":"Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniae","volume":"50","author":"Madaras-Kelly","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jac\/40.3.458","article-title":"The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin","volume":"40","author":"Brenwald","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib15","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/514920","article-title":"Antibiotic resistance caused by gram-negative multidrug efflux pumps","volume":"27","author":"Nikaido","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1592\/phco.23.7.916.32722","article-title":"The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria","volume":"23","author":"Aeschlimann","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib17","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/AAC.46.8.2651-2655.2002","article-title":"Longitudinal assessment of antipneumococcal susceptibility in the United States","volume":"46","author":"Jones","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib18","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1128\/JCM.38.11.4298-4299.2000","article-title":"Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY antimicrobial surveillance program (North America, 1997\u20131999)","volume":"38","author":"Jones","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib19","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","article-title":"Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.46.1.119-124.2002","article-title":"Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000","volume":"46","author":"Davies","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0732-8893(02)00498-4","article-title":"Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada","volume":"45","author":"Zhanel","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/AAC.43.1.187","article-title":"Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae","volume":"43","author":"Gill","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"5529","key":"10.1016\/j.ijantimicag.2004.08.003_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1061217","article-title":"Complete genome sequence of a virulent isolate of Streptococcus pneumoniae","volume":"293","author":"Tettelin","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1469-0691.2003.00482.x","article-title":"Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae","volume":"9","author":"Brenwald","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.42.8.2032","article-title":"Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae","volume":"42","author":"Brenwald","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/48.3.365","article-title":"Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae","volume":"48","author":"Nagai","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jac\/dkg469","article-title":"Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England","volume":"52","author":"Johnson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.46.3.808-812.2002","article-title":"Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae","volume":"46","author":"Piddock","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in.","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib30","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/AAC.42.11.2956","article-title":"Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract","volume":"42","author":"Piddock","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.43.3.672","article-title":"Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection","volume":"43","author":"Lacy","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jac\/47.4.435","article-title":"In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae","volume":"47","author":"Zhanel","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib33","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.45.6.1654-1659.2001","article-title":"Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae","volume":"45","author":"Coyle","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jac\/dkf022","article-title":"Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae","volume":"49","author":"Zhanel","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/AAC.47.3.1096-1100.2003","article-title":"Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model","volume":"47","author":"MacGowan","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0732-8893(02)00417-0","article-title":"Pharmacodynamics of 750mg and 500mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae","volume":"44","author":"Lister","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib37","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/514909","article-title":"Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria","volume":"27","author":"Hancock","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6799","key":"10.1016\/j.ijantimicag.2004.08.003_bib38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib39","doi-asserted-by":"crossref","unstructured":"NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 to May 1999. Issued June 1999. Am J Infect Control 1999;27:520\u201332.","DOI":"10.1016\/S0196-6553(99)70031-3"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib40","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.44.3.658-664.2000","article-title":"Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa","volume":"44","author":"Maseda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jac\/dkg390","article-title":"A new member of the tripartitie multidrug efflux pumps, Mex-VW-OprM, in Pseudomonas aeruginosa","volume":"52","author":"Li","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/AAC.43.6.1340","article-title":"Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa","volume":"43","author":"Lomovskaya","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/48.4.549","article-title":"Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia","volume":"48","author":"Zhang","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/107662903322762743","article-title":"Role of efflux pumps and mutations in genes for topoisomerase II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains","volume":"9","author":"Oh","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","article-title":"High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation","volume":"46","author":"Nakajima","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0924-8579(03)00009-8","article-title":"Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa","volume":"21","author":"Higgins","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/48.4.553","article-title":"In vivo selection of a target\/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy","volume":"48","author":"Le Thomas","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.44.3.710-712.2000","article-title":"Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"44","author":"Jalal","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical strains of Pseudomonas areuginosa overproducing Mex-AB-OprM and MexXY efflux pumps simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib51","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JB.182.11.3142-3150.2000","article-title":"Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance","volume":"182","author":"Lee","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib52","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/AAC.41.11.2540","article-title":"Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa","volume":"41","author":"Kohler","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/AAC.45.2.571-576.2001","article-title":"Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats","volume":"45","author":"Join-Lambert","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/43.3.345","article-title":"The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility","volume":"43","author":"MacGowan","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/37.4.703","article-title":"A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa","volume":"37","author":"Madaras-Kelly","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316814","article-title":"Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy","volume":"112","author":"Jumbe","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib57","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/383320","article-title":"Relationship between fluoroquinolone area under the curve:minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia","volume":"189","author":"Drusano","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/AAC.43.4.988","article-title":"Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine","volume":"43","author":"Markham","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib59","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1128\/AAC.41.9.1973","article-title":"Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae","volume":"41","author":"Zeller","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib60","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1021\/jm9904598","article-title":"Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin","volume":"42","author":"Renau","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000077280","article-title":"A multidrug efflux inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates","volume":"50","author":"Coban","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib62","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.bmcl.2003.07.024","article-title":"MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization","volume":"13","author":"Nakayama","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib63","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1016\/j.bmcl.2003.07.027","article-title":"MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds","volume":"13","author":"Nakayama","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib64","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/S0960-894X(03)00556-0","article-title":"Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa","volume":"13","author":"Renau","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0960-894X(02)00006-9","article-title":"Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa","volume":"12","author":"Renau","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib66","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.bmcl.2003.07.030","article-title":"The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors","volume":"13","author":"Watkins","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1369-5274(98)80083-0","article-title":"Multiple antibiotic resistance and efflux","volume":"1","author":"Nikaido","year":"1998","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2004.08.003_bib68","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1378\/chest.119.4.1114","article-title":"Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects","volume":"119","author":"Gotfried","year":"2001","journal-title":"Chest"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904002821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904002821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T03:54:14Z","timestamp":1585972454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904002821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0924857904002821"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.08.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}